Healthy volunteers test new autoimmune drug in early safety trial
NCT ID NCT06827457
First seen Jan 10, 2026 · Last updated May 19, 2026 · Updated 22 times
Summary
This early-stage study tested a single injection of a new drug called GenSci120 in 58 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it, not to treat any disease. Participants were randomly assigned to receive either the drug or a placebo, and no one knew which they got. The results will help guide future studies in people with autoimmune diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Huashan Hospital
Shanghai, Shanghai Municipality, 20040, China
Conditions
Explore the condition pages connected to this study.